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Executive Summary 
This paper discusses how an evaluation was done on a peer cancer support group, Cancer 
Awareness Resource and Education (CARE). The peer cancer support group, CARE, is the only cancer 
support group provided at Zuckerberg San Francisco General Hospital and Trauma Center (ZSFG), San 
Francisco City and County’s safety-net hospital. ZSFG serves a large underserved population such as 
those who are low-income, racial and ethnic minorities, and struggling with a medical condition. 
Evaluation is pertinent to understanding the efficacy of the program and to gaining support for the 
program’s continual existence.    
The evaluation included in-depth interviews with CARE participants to understand what is most 
valued and gained from participating in the program. Social support was a common theme that emerged 
in the analysis of the interviews, so pre-survey and post-survey were created to measure perceived social 
support and to take inventory of health-related benefits from participating in CARE. Due to the timing 
of the fieldwork, data from the post survey has not yet been collected, but the method of creating the 
evaluation, the in-depth interview findings, and the pre-survey findings are reported. Results from this 
project will be provided to CARE management to improve programing of CARE and to substantiate the 
continual support for the CARE program.  
This paper recommends evaluation methods and tools to evaluate CARE’s efficacy. In-depth 
interviews and short, simply worded in-session paper surveys examining perceived social support are 
recommended for CARE. This paper also recommends further research and advancements toward 
creating best practices for peer cancer support group evaluations. To improve peer support group 
evaluation methods and tools, all stakeholders especially cancer survivor participants need to be 
involved. 
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Abstract 
Introduction: For many years, health care organizations have offered peer cancer support groups to 
cancer survivors, but peer cancer support group evaluation is not standardized. Without a clear and 
consistent evaluation, it may be difficult to understand the efficacy of and gain support for peer cancer 
support groups. In this paper, I discuss how an evaluation was created for a peer cancer support group 
called Cancer Awareness Resource and Education (CARE).  
Methods: In-depth interviews with CARE participants were conducted and pre-survey and a post-
survey were developed. The in-depth interviews included a convenience sample of eight individuals, 
two individuals from the following ethnic groups: African/African American, Asian/Pacific Islander, 
Caucasian, and Latino/Chicano. A pre-survey was also piloted on 25 CARE participants during a 
seminar.  
Results: Social support was highly valued by CARE participants, with interviewees stating they came to 
CARE to meet other cancer survivors, they gain social support, and they continued to come to obtain 
additional social support. Since social support was commonly valued, a pre-survey and post-survey was 
created to measure social support.  
Discussion: Conducting qualitative interviews to help create quantitative surveys seemed to be most 
effective for this project since no standardized peer cancer support evaluation method or tool exist. 
Social support seemed to be highly valued and leveraged in CARE, and should be the focus of future 
evaluation of cancer peer support groups. 
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Introduction 
Cancer survivorship is an emerging area of care that has been driven by improved survival in the 
face of a historically deadly disease. Cancer forms when abnormal, old, or damaged cells divide without 
control, losing its functionality (NCI, 2015). Cancer can start almost anywhere in the body, can spread, 
and can lead to death (NCI, 2015). In the past cancer was regarded as a death sentence, but that has 
changed with cancer survival improving. It was estimated 13.7 million Americans were living with a 
history of cancer in 2012; that number is expected to be 18 million by 2020 (Siegel et al., 2012). There 
is a large population of people living with a history of cancer, and they are now tending to live longer. 
Since 1974, 5-year survival for the most common types of cancer combined has increased (Jemal, et al., 
2017). The majority of cancer survivors, about 67%, were diagnosed 5 or more years ago, and 17% were 
diagnosed 20 or more years ago (American Cancer Society, 2016).  
As cancer survival has improved, a definition of a cancer survivor has emerged. The National 
Coalition for Cancer Survivorship selected the words “cancer survivor” to convey two important 
messages: a message of hope for life after cancer, and a message to consider what happens beyond 
treatment (Ullman, 2014). Since there are more and more cancer survivors that need help beyond 
treatment, it seems pertinent to discuss cancer support that goes beyond medical intervention.  
One way to provide support to cancer survivors is to offer a cancer support group. This paper 
will discuss first, how a cancer survivor peer support group was evaluated and second, will provide 
recommendations on method and tools for future evaluations and on program improvement.  
Literature Review 
Being a cancer survivor is at the forefront of my self-awareness. It enters into the conversations 
that I have with myself about what I want to do, how I want to spend money, how I want to spend 
time, my energy, all of that. Being a cancer survivor has added another dimension to my identity. 
I am a cancer survivor. — Dr. Mortimer Brown, 80, colorectal cancer survivor diagnosed 
(President’s Cancer Panel, 2004) 
Evolution of Cancer Survivor Definition 
Cancer survivorship is expanding and still being understood. Even the definition of a cancer 
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survivor has changed over time as cancer survival and cancer survivorship care have grown. When 
cancer was considered incurable, the term “survivors” was used to describe family members who 
experienced the loss of loved ones to cancer (Leigh, 1996). As cancer survival increased, physicians 
used the term “cancer survivor” to describe a person surviving cancer for five years or more after 
diagnosis or treatment (Leigh, 1996). The National Coalition for Cancer Survivorship (NCCS) does not 
use a five-year cancer survival condition. According to the NCCS, people are cancer survivors from the 
time they are diagnosed with cancer until the time they die (NCCS, 2014). The National Cancer Institute 
(NCI) has expanded the definition of cancer survivors to include people such as caregivers and family 
members who are affected by the cancer of loved ones (Aziz, 2002). For this paper, I will use the 
NCCS’s definition of cancer survivor. I will refer to people diagnosed with cancer as cancer survivors 
from the time of diagnosis on.   
Cancer Incidence and Survival in the San Francisco Bay Area 
Cancer is a prevalent disease not only in the United States, but also in the San Francisco Bay 
Area. In the San Francisco Bay Area, the five most common invasive cancers are: breast, prostate, lung 
and bronchus, colorectal, and melanoma cancer (Cancer Prevention Institute of California, 2016). 
Cancer kills more San Franciscans than any other cause (Hiatt & Ashworth, 2016). From 2009-2013, 
San Francisco cancer incidence rate has been 420.9 per 100,000 people (San Francisco Health 
Improvement Partnership, 2016a). From 2012-2014, San Francisco all cancer mortality rate has been 
135.5 per 100,000 people, a decrease from 151.2 per 100,000 in 2009-2011 (San Francisco Health 
Improvement Partnership, 2016b). Fortunately, mortality rates in San Francisco have trended downward 
since 2009 (San Francisco Health Improvement Partnership, 2016b). There is a decrease in mortality and 
an increase in cancer survivors in San Francisco. According to Surveillance Epidemiology and End 
Results, NCI’s cancer registry of several states and two major metropolitan areas including San-
Francisco-Oakland, there is an upward trend in the number of cancer survivors in the San Francisco Bay 
Area (Parry, Kent, Mariotto, Alfano, & Rowland, 2011). Given that the cancer survivor population is 
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growing in San Francisco, there is a high need to focus on cancer survivorship.  
Physical Effects 
People with cancer can improve their survival with diagnosis and treatment, but there are 
subsequent physical side effects from these interventions. Most cancers are given a diagnosis and stage 
(Cancer Research UK, 2014a). There are generally four stages: stage I includes small primary tumors 
that have not spread to other organs; Stage II and III include larger or more extensive primary tumors 
with or without cancer in nearby organs; Stage IV includes cancer that has spread from where it 
originated to other organs (Cancer Research UK, 2014b). Medical interventions are generally 
determined by type and stage of cancer, possible side effects, patient preferences, and overall patient 
health (Blinman, King, Norman, Viney, & Stockler, 2012). Some common cancer treatments are 
surgery, chemotherapy, and radiation. Undergoing cancer treatments may be difficult depending on the 
factors stated above because there are a variety of subsequent side effects. According to the National 
Cancer Institute, there are numerous common physical side effects from cancer treatment are anemia, 
appetite loss, bleeding and bruising, constipation, delirium, diarrhea, edema, fatigue, hair loss, infection 
and neutropenia, lymphedema, memory or concentration problems, mouth and throat problems, nausea 
and vomiting, nerve problems, pain, sexual and fertility problems, skin and nail change, sleep problems, 
and urinary and bladder problems. 
Emotional Effects 
In addition to physical side effects, studies have shown serious emotional effects from having 
cancer. According to the American Cancer Society, most people faced with cancer experience some 
degree of depression, anxiety, fear, or distress. Prevalence is estimated to be between 10% and 25% for 
major depressive disorder (Pirl, 2004). Diagnosable anxiety disorders are estimated to be 10%-30% in 
cancer survivors (Greer et al., 2011). Distresses can span from before to even after cancer treatment. A 
study found that 51% of newly diagnosed lung cancer patients reported clinically significant distress on 
the Distress Thermometer (Steinberg et al., 2009). Another study found that the prevalence rate of breast 
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cancer-related Post Traumatic Stress Disorder is 6% even after treatment (Andrykowski, Cordova, 
Studts, & Miller, 1998).  
Understanding the Multiple Effects of Cancer 
Cancer survivors are dealing with multiple serious issues. Testimony from cancer survivors can 
better describe the depth of distress. Cancer survivors provided testimonies to the President of the 
United States of America through the President’s Cancer Panel to explain the immense challenges 
cancer survivors face. In the following testimony, a cancer survivor described her anxiety of cancer 
recurrence and cancer treatment complications even many years after treatment. 
My concerns as a survivor have evolved the farther away I have gotten from treatment… During 
my treatment and for several years after...my primary concern was recurrence… [Now] I worry 
about secondary cancers...and problems due to my [treatment]... I am in premature menopause 
because of the high doses of chemotherapy I received, so I worry about osteoporosis, sexuality, 
cardiac problems, and yes, even wrinkles. —Karen Dyer, 24, rhabdomyosarcoma survivor 
(President’s Cancer Panel, 2004) 
 
Cancer survivors experience a considerable amount of physical and emotional issues relating to cancer 
that begins from the time of diagnosis on. There are even issues that are beyond physical and emotional 
problems that complicate multiple parts of life and overall quality of life. The follow testimony is from a 
cancer survivor who is a mother and head of household.  
[My husband] decided to move on. I had three young children depending on me. There was no 
room for me to be sick but I didn’t have a choice... The ‘repo’ man came to take our car… [My 
kids] did odd jobs so that I could have the gas money to go back and forth [to treatment]… I 
became so depressed until I just didn’t want to live anymore… [My kids said,] ‘You can’t give 
up. You have come so far… — Barbara Young, 50, breast and stomach cancer survivor, 
diagnosed at ages 34, 41, and 44 (President’s Cancer Panel, 2004) 
 
In the case of this cancer survivor, cancer also affected her family relationships, her financial stability, 
and even her identity as a mother and provider to her children. Cancer can affect a person’s overall 
quality of life. According to the Centers of Disease Control and Prevention, the diagnosis of cancer is a 
threat to a cancer survivor’s physical, psychological, social, spiritual, and economic wellbeing (Centers 
of Disease Control and Prevention, 2014). The impact cancer has on cancer survivors’ overall wellbeing 
and quality of life can make cancer survivors very vulnerable. 
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Assisting Cancer Survivors with Support Groups 
The unique vulnerabilities of cancer survivors suggest they may need several avenues of help. 
One avenue of assistance can be through cancer support groups. There are several types of cancer 
support groups. Cancer support groups may be convened in person, on the web, or on the telephone. 
Cancer support groups can be lead by medical professionals, a fellow cancer survivor described in this 
paper as a peer, or another type of person. For this project, I will focus on in-person peer cancer support 
groups. Cancer support groups can serve various purposes depending on the design, vision, mission, and 
goals of the program.  
The Purpose of Cancer Support Group Evaluations 
Cancer support group evaluations can be a good way to know how cancer survivors are faring in 
various aspects of life, and to know how cancer support groups are helping its cancer survivor members. 
Evaluations such as process and outcome evaluations on cancer support group participants can measure 
respectively how cancer survivors are improving while participating in the cancer support group and 
how cancer survivors are doing overall. Cancer support group evaluations can also be an ideal way to 
obtain cancer survivorship information by providing institutions a large and convenient sample of cancer 
survivors. 
Evaluation Methods 
There are many ways evaluations on can be done on cancer support groups. Three main methods 
of evaluations exist: qualitative, quantitative, and mixed-methods that use both quantitative and 
qualitative methods. Quantitative data involves numbers while qualitative data involves words, videos, 
and pictures. Quantitative data usually is collected from a larger sample of people compared to 
qualitative data, but qualitative data captures people’s voices and detailed explanations (Lee, 2013). 
Both qualitative and quantitative data are valuable, but decision makers tend to like quantitative data 
(Lee, 2013). According to a systematic review on peer cancer support groups, there is a lack of guidance 
on evaluations; therefore, it may be unclear how to conduct a rigorous evaluation (Campbell, Phaneuf, 
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Deane, & 2004).  
Quantitative Survey Tools 
There are several quantitative survey tools used by cancer support programs like those presented 
in Table 1. The survey tools in Table 1 were selected for presentation because they are commonly used 
to measure multiple aspects of life. According a national survey on patient navigation and cancer 
survivorship programs, the National Cancer Network Distress thermometer is the most common 
assessment tool used in about 50% of patient navigation and cancer survivorship programs (George 
Washington Cancer Institute, 2013). An authority in cancer, National Comprehensive Cancer Network, 
provides the National Comprehensive Cancer Network Distress Thermometer to help cancer survivors 
describe the distress they are feeling. Though this is popular, it only allows cancer survivors to provide 
one overall score to describe their distress. It is not granular enough to pick smaller changes and it may 
not be suitable for a pretest and posttest evaluation design. Functional Assessment of Cancer Therapy – 
General(FACT-G) is a survey used in about 8% of cancer patient navigation and cancer survivorship 
programs (George Washington Cancer Institute, 2013). FACT-G evaluates health-related quality of life 
Table 1 
Example Survey Tools 
 
Survey Tools Source 
National Comprehensive Cancer Network 
Distress Thermometer 
Jacobsen, et. al., 2005 
FACT-G Winstead-Fry & Schultz, 1997 
EORTC Quality of Life Questionnaire C30 Aaronson, et al, 1993 
Edmonton Symptom Assessment System 
(ESAS)  
Bruera, Kuehn, Miller, Selmser, & 
Macmillan, 1991 
SF-12 Health survey Ware, Kosinski, & Keller, 1996 
Quality of Life Patient/Cancer Survivor 
Version (QOL-CSV) 
Ferrell, B.,. et al, 2012 
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for general cancer patients. It is has several Likert scales questions and is designed to pickup more 
granular chances, but it does not measure spiritual and financial wellbeing. Like FACT-G, other surveys 
ask several questions with a Likert scale, but may not cover all five dimensions of wellbeing affected by 
cancer as described by the CDC. The only survey listed that uses a Likert scale and measures all five 
dimensions of wellbeing is the Quality of Life Patient/Cancer Survivor Version (Ferrell, B., Hassey-
Dow, K., Grant, M. et al, 2012). Unfortunately, literature has not found it to be a common survey tool 
used to evaluate cancer support groups.  
Lack of Standardized Qualitative Survey Tools 
Though there are many survey tools to assess cancer support programs that capture various 
aspects of cancer survivorship, no one survey clearly prevails, is deemed superior over all others, and is 
commonly used. The National Cancer Institute’s measures database currently lists 192 survey tools 
relating to cancer survivorship. In the database the tools can be reviewed and rated up to five stars, but 
only 4 survey tools currently have five stars with only one to four reviewers. This may indicate that 
there are many survey tools and little consensus on what survey tool is best. The Malin, Sayers, and 
Jefford 2011 study on quality of cancer care corroborates this by concluding that there is currently is no 
set of validated survey tools specific to cancer survivorship. In addition to this, the American Society of 
Clinical Oncology states that there is a lack of guidance for assessment and management for long-term 
cancer survivorship support, and suggests that a standardized outcome measure is needed. A systematic 
review on the efficacy of cancer peer support groups specifically states, “This field would also benefit 
from more consistent use of standard outcome measures” (Campbell, Phaneuf, Deane, & 2004). Another 
systematic view on cancer support groups finds little research specifically on the effectiveness of peer 
support groups, and urges for more studies (Hoey, Ieropoli, White, Jefford, 2008). Currently, there 
seems to be no standard way to precisely evaluate how cancer survivors are doing. To date, there seems 
to be no standardized tools to rigorously and accurately assess the efficacy of peer cancer support 
groups.  
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CARE Agency Profile 
The Cancer Awareness, Resources, and Education (CARE) provides a peer cancer support group 
in the form of 9-12 weeks seminar series to Zuckerberg San Francisco Hospital and Trauma Center 
(ZSFG formally known as San Francisco General Hospital or SFGH) patients. Since ZSFG is a safety-
net hospital, it serves a large underserved community. CARE provides seminars series in three 
languages: English, Spanish, and Cantonese. CARE staff also supports their participants by making 
home calls, reminders, and giving additional help as needed. CARE is also provided at no cost to the 
participant. 
History 
In 2001 the SF Foundation approached the San Francisco General Hospital (SFGH) Foundation 
with a donation from a donor interested in establishing programs for low-income people with cancer. 
The donation was generously given to CARE by a former SFGH cancer patient. That year the executive 
director of the SFGH Foundation appointed the director of patient education to develop a program. Since 
October of 2002, the CARE program has provided cancer support to thousands of medically 
underserved cancer patients. The CARE support group model is based on a tailored educational program 
with a loving and supportive atmosphere. The English and Spanish CARE seminar series began in 
October 2002. The Chinese seminar series began in 2005. Currently, CARE is a program within and 
overseen by Community Wellness Program. The Community Wellness Program has its own center on 
the second floor of the hospital in the Community Wellness Center across from the hospital cafeteria.  
Many patient walk by this room. The Community Wellness Center houses various programs that 
promote health and wellness.  
The following CARE vision, mission, and objectives are presented and edited for clarity. This is 
not the initial vision, mission, and goals created by the original CARE program planning team. 
Vision 
All cancer survivors thrive with hope and purpose throughout their cancer journey at ZSFG.  
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Mission 
To deliver humanistic, culturally, and linguistically appropriate health education and 
psychosocial support. 
Goals 
o Build a cohesive and expanding cancer survivor community within ZSFG.  
o Encourage personal awareness, so individuals can work toward fulfilling their health and 
wellness needs in order to enhance their quality of life. 
o Improve relationships and communication between cancer survivors and health 
professionals   
Funding 
CARE was awarded the California Pacific Excellence in Patient Education Award and the AMA 
Innovative Approaches to Patient Centered Communication Award in 2002. In 2004, 
Hematology/Oncology division at SFGH along with Avon Foundation monies supported CARE staff. 
Due to various reasons, CARE funding since the initial support has been tenuous. Currently CARE is 
funded by a grant from AVON Foundation, and the San Francisco Department of Public Health and 
ZSFG. The CARE Coordinator works 40% of full-time equivalent for CARE. The CARE Director also 
works 40% of full-time equivalent for CARE. Donations for CARE are currently diminishing, so CARE 
is in need of extra funding.   
Service offerings 
CARE provides support groups once a week for a 9-12 week long three times annually. The 
topics vary, but all are related to cancer. CARE is provided in the three major languages spoken by 
patients: English, Spanish, and Cantonese. Each language has its own seminar series. CARE is designed 
for low-income participants, but participants can come from a range of socioeconomic statuses. At the 
CARE seminars, food is provided, peer discussion is encouraged, and educational presentations are 
given. English and Spanish CARE are conducted similarly. Both groups beginning with a one hour to 
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one and a half hour check in process that allows attendees to introduce themselves and their cancer 
related updates to the group. The next thirty minutes to an hour, an expert presents. Lastly, a facilitator 
or volunteer participant gives closing remarks. Chinese CARE runs differently and only provides a 
lengthy presentation. At the end of each CARE seminar, a healthy dinner is provided to the participants 
to take home to encourage healthier eating. CARE also makes weekly calls to established and 
prospective participants to see how they are doing and reminds them to come to CARE. If any CARE 
participant is in extreme need they are typically referred to the CARE director. The CARE director has 
health education experience, so she can provide individualized education or help the participant find the 
appropriate resources at ZSFG. 
Target population/Client mix 
CARE accepts any cancer survivor that shows up at and registers with the Community Wellness 
Center at ZSFG; however, CARE has a relationship with various ZSFG departments such as: 
Hematology/Oncology, Breast Clinic, Physical Therapy, Chemotherapy, Women’s Clinic, Family 
Practice, and Social Work. CARE has a closer history with Hematology/Oncology. Compared to the 
General Population of cancer patients ZSFG, Oncology Patients tend to be ≥10yrs younger at diagnosis 
(52 years old vs. 63 years old) and present at more advanced stages (10% v. 5%). They also tend to have 
poorer survival outcomes (60% 1-year mortality v. 30% 1-year mortality) and up to 50% do not speak 
English. 
Providers from ZSFG clinical departments can refer patients to CARE, or cancer survivors from 
the community can simply go to CARE. CARE accepts all attendees, but since CARE participants 
usually come from ZSFG clinics, they tend to be lower-income, younger, have more advanced cancer, 
and have fewer English language skills. CARE participants are of all racial and ethnic backgrounds. 
Many CARE participants face challenges related to poverty, unstable housing, immigration status, 
language barriers, literacy difficulties, substance use, and/or mental health issues. They may lack 
computer literacy, access to the Internet, and/or connections to helpful people/resources. CARE 
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participants may feel mistrust of the medical establishment and related institutions. They also may be 
less disposed to asking health providers questions regarding care or treatment plan.  
Culture 
From experience, the support group has a loving, supportive, and uplifting culture. The 
participants seem to enjoy being around peers who experienced a similar fight against cancer. 
Participants find comfort with their peers’ honesty and encourage a culture of honesty and humility. 
Facilitators encourage curiosity and are willing to slow the workshop to keep discussion going. The 
participants enjoy CARE, but may feel at odds with ZSFG since ZSFG may not meet all of their needs 
and desires given that ZSFG is a safety-net with limited resources and overstretched staff. CARE 
participants have a mixture of appreciation and honest criticism of resources at ZSFG.  
Agency Needs and Challenges 
CARE needed evaluation of the program for two main purposes. The primary purpose is to learn 
from participants how we can improve the program to meet their needs. The secondary purpose was to 
do an evaluation on the efficacy of CARE to provide justification of support to current and prospective 
stakeholders. CARE’s original goals were very broad and a formal program evaluation on the efficacy of 
CARE has not been planned or conducted. Without best practices on evaluation CARE needed input 
from researchers to conduct the evaluation.  
 An analysis was done to identify strengths, weaknesses, opportunities, and threats called a 
SWOT analysis. A SWOT analysis is located in Appendix A. After	doing	the	SWOT	analysis,	it	is	obvious	that	lacking	funds	provides	a	significant	weakness	and	threat	because	it	can	lead	to	CARE	dying.	To	obtain	funds,	it	seems	as	if	CARE	should	be	specific	on	what	it	has	achieved	and	how	it	is	achieving	that,	so	CARE	can	substantiate	receiving	financial	support.	The	strengths	are	that	CARE	already	has	many	presenter	and	community	organization	relationships,	and	has	a	loyal	participant	following.	CARE	can	use	those	professional	relationships	to	help	get	funding.	CARE	can	use	its	
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loyal	participant	followings	to	get	feedback	and	support	in	defining	CARE,	evaluating	CARE,	and	improving	the	program.	
Methods	
Evaluation	Methods	There	are	two	major	research	questions	for	this	project:	first	is	what	do	CARE	participants	most	value	about	CARE,	second	is	how	efficacious	is	CARE	in	providing	that	value.	The	research	design	included	in-depth	interviews	used	to	address	the	first	major	question,	and	a	pilot	pre-survey	and	post	survey	used	to	address	the	second	major	question.	The	pre-survey	and	post-survey	were	chosen	because	there	is	a	start	and	end	time	within	each	series,	so	there	is	a	chance	to	show	changes	before	and	after	participating,	and	surveys	can	yield	numerical	results	necessary	to	easily	depict	the	efficacy	of	the	program	to	stakeholders.	In-depth	interviews	were	chosen	because	cancer	survivorship	is	complicated	and	the	original	goals	of	CARE	were	too	broad	to	identify	specific	constructs	that	should	be	measure	in	a	quantitative	survey.		The	data	from	the	in-depth	interviews	was	used	to	develop	the	survey.	This	method	was	used	to	ensure	what	is	evaluated	in	the	survey	matches	the	needs	and	goals	of	its	participants	as	suggested	by	Gottilieb	&	Wachala’s	2007	systematic	review	on	cancer	support	groups.	It’s	important	to	allow	participants	to	define	goals	and	outcome	of	the	program	because	it	otherwise	may	not	be	wanted	or	even	obtainable	by	participating	in	a	support	group	(Gottlieb	&	Wachala,	2007).		
In-depth	interviews	The	in-depth	interviews	were	conducted	with	eight	CARE	participants,	a	male	and	female	from	the	following	racial/ethnic	groups:	African	American/African,	Asian/Pacific	Islander,	Caucasian,	and	Latino/Chicano.	This	was	a	convenient	sample	of	people	who	were	approached	by	me	after	a	few	CARE	sessions	and	accepted	my	invitation	to	be	interviewed.	I	went	to	several	CARE	sessions	and	participated	in	group	activities,	so	they	would	get	familiar	with	me.	Over	a	few	
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weeks	from	May	to	July	2017,	I	introduced	myself	to	several	participants	as	a	student	researcher	who	wanted	to	hear	about	their	experiences	in	confidence.	For	those	who	accepted	the	invitation	to	be	interviewed,	I	scheduled	interviews	at	a	convenient	time	in	a	private	room	in	the	hospital.	The	interviews	were	audio	recorded	and	conducted	using	an	interview	guide	and	interview	data	collection	form.	The	interview	lasted	between	60	to	90	minutes.	The	names	of	the	interviewee	were	not	collected	and	a	unique	record	number	was	assigned	to	each	interviewee	instead.	The	unique	record	number	kept	confidentiality	and	reduced	bias	during	analysis.	The	interview	guide	and	collection	form	were	produced	with	input	from	CARE	staff,	a	CARE	participant,	and	two	researchers	both	with	qualitative	research	experience.	The	questions	are	open-ended	questions.	Before	each	interview,	a	script	was	read	to	each	participant	that	asked	for	permission	to	do	an	interview,	audio	record	it,	and	use	the	data	for	a	CARE	evaluation	project.	Each	person	interviewed	was	told	that	the	interview	can	be	ended	at	any	time	and	any	questions	can	be	skipped.	The	interview	guide	and	data	collection	form	are	in	Appendix	C.	The	first	part	of	the	interview	in	section	I	and	II	is	designed	to	capture	what	participants	value	about	CARE	by	asking	question	around	why	people	came	to	CARE,	why	they	returned	to	CARE,	and	what	did	they	gain	from	CARE.		CARE	staff	suggested	question	about	CARE’s	vision	and	competing	resources.	The	third	section	asked	participants	what	they	think	the	vision	of	CARE	should	be.	The	fourth	section	asked	about	how	to	best	get	feedback.	The	fifth	was	used	to	identify	any	competing	programs.	The	interview	was	then	transcribed	and	key	testimonies	describing	themes	of	the	interviews	were	extracted	and	reported.		
Survey	The	survey	was	designed	after	conducting	interviews	with	input	with	CARE	staff,	a	CARE	participant,	and	two	researchers.	Due	to	scheduling	challenges,	the	pre-survey	was	piloted	on	July	11,	2017	the	second	CARE	session	of	the	summer	2017series	to	whoever	was	present	at	the	
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Community	Wellness	Center.	Due	to	unaligned	timing	of	the	internship	and	summer	2017	CARE	series	the	post	survey	was	not	done.	During	the	CARE	seminar	on	July	11,	2017	the	facilitator	announced	at	the	beginning	of	the	session	that	the	pre-survey	would	be	piloted	after	introductions.	Prior	to	passing	out	the	surveys,	I	announced	my	name,	and	said	my	survey	was	designed	to	evaluate	and	improve	CARE	and	that	anyone	was	welcomed	to	do	my	survey	if	they	liked.	Volunteers	then	passed	out	the	survey	while	CARE	management	was	not	present.	Surveys	and	pens	were	offered	to	all	who	accepted	it.		After	the	survey	was	passed	out,	I	let	participant	know	they	can	ask	me	question	or	feedback	before	we	moved	on	with	the	rest	of	the	CARE	session.	Valuable	feedback	was	then	used	to	edit	the	survey	included	in	Appendix	C.	Volunteer	collected	all	the	surveys	after	everyone	was	done.	It	took	approximately	20	minutes	for	all	the	survey	to	be	complete.	In	the	survey,	it	asks	demographic	information,	type	of	cancer,	cancer	stage,	and	place	in	cancer	care	continuum	need	for	CARE.		The	pre-survey	asks	for	name,	but	this	was	only	done	by	request	of	CARE	staff,	so	CARE	staff	can	identify	if	someone	is	in	dire	need.	The	name,	however,	was	removed	and	a	record	number	was	provided	before	pooling	data	together	and	analyzing	for	this	study.	This	was	used	to	ensure	confidentiality	and	reduce	biases	in	analysis	and	reporting.	Additionally,	at	the	top	of	the	survey	it	states	that	the	survey	is	confidential,	will	be	combined	into	a	report	for	CARE	improvement,	and	will	not	affect	participants’	participation	in	CARE.	This	statement	is	used	to	show	there	will	be	confidentiality,	and	to	elicit	a	more	honest	response.		From	interviews,	social	support	seemed	to	be	a	theme,	with	all	eight	participants	speaking	about	receiving	support	from	other	cancer	survivors.	Therefore,	the	survey	used	an	adapted	validated	perceived	social	support	survey	tool	with	Cronbach’s	alpha	of	0.88	(Li,	Chen,	&	Popiel,	2015).	The	scoring	for	analysis	method	was	also	adapted	for	simplicity.	To	cross-reference	the	findings	of	the	interviews,	a	question	on	the	main	reason	for	coming	to	CARE	was	added.	It	was	
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used	to	make	sure	peer	support	is	relevant	to	the	large	non-interviewed	group.	Other	information	outside	of	the	scope	of	the	project	was	also	collected	by	the	request	of	CARE	staff.	Questions	on	when	they	learned	about	CARE	was	out	of	the	scope,	but	was	included	to	determine	challenges	in	outreach.	After	the	pre-survey	was	conducted,	two	CARE	participants	gave	feedback	mainly	on	the	Likert	scale	wording,	so	the	second	pre-survey	version	and	post-survey	were	modified	based	on	this	feedback.	Only	the	pre-survey	results	are	reported	in	this	paper	since	the	seminar	series	extends	beyond	the	project	deadline.			The	post-survey	is	shown	in	appendix	D.	In	addition	to	the	components	of	the	survey	mentioned	above,	the	post-survey	asks	participants	to	inventory	the	variety	of	benefits	gained	form	participating	in	CARE.	This	inventory	was	added	to	attempt	to	quantify	the	number	of	people	gaining	certain	health-related	benefits.	This	component	was	important	to	add	so	that	it	can	be	used	to	substantiate	support	from	stakeholders	interested	in	health-related	outcomes.	The	post-survey	will	be	done	the	last	day	of	the	summer	2017	CARE	series	and	will	not	be	reported	in	this	paper.		
Results 
In-depth Interview Findings 
 There were eight in-depth interviews each with a record number 001 to 008. Table 2 shows each 
record number’s demographic information, cancer types and stage, and year diagnosed with the cancer. 
Male and females from African	American/African,	Asian/Pacific	Islander,	Caucasian,	and	Latino/Chicano	racial/ethnic	groups	were	interviewed. The average age of the interviewees was 59 
years old. The ages ranged from 51 to 69 years old. Most were diagnosed in 2016. The earliest diagnosis 
was in 2006 and the latest was in 2016. Three out of eight had stage 4 cancer. Stage 1 and 2 as well as 
people without a stage were represented. Interviewees had a variety of diagnoses, but three had breast 
cancer and two had myeloma. Most had 1 type of cancer. One person has cancer in multiple organs. 
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Table 2 
 
In-Depth Interviewee Demographics And Cancer Diagnosis Information 
Record number Gender 
(M for male, 
F female) 
Age Race/Ethnicity Cancer type, 
Stage 
Year 
Diagnosed 
001 M 52 Latino/Chicano Myeloma, 
Unknown 
stage 
2016 
002 M 57 Caucasian Colon, Stage 4 2016 
003 F 53 Latino/Chicano Lung, Stage 4 2016 
004 F 69 Caucasian Breast, Stage 2 2015 
005 F 59 Asian/Pacific 
Islander 
Stomach, 
Ovary, Breast, 
Stage 4 
2006 
006 M 69 African/African 
American, 
Caribbean 
Chronic 
Lymphocyte 
Leukemia, No 
Stage provided 
2009 
007 M 60 Asian/Pacific 
Islander 
Breast, Stage1 2016 
008 F 51 African/African 
American 
Multiple 
Myeloma, No 
stage provided 
2011 
 
 In the in-depth interviews we asked how best to get feedback from CARE participants; most 
people said in-session surveys were best with a minority of people suggesting direct feedback. Four out 
of eight said paper surveys fielded during CARE sessions works well. Three said they prefer to give 
direct feedback in person to CARE staff. One said he didn’t feel comfortable giving feedback at all. A 
few suggested other survey designs. Two suggested having short surveys. One suggested having a 
survey online, so it can be completed anytime. Table 3 provides quotes showing preferences for giving 
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feedback to CARE staff about CARE performance. From the surveys, two points to keep in mind 
include length and time allotted to complete the surveys.  
Table 3 
 
In-Depth Interview Quotes On Feedback Preferences 
Main questions/ 
comment type 
Quotes 
How would you like 
to give feedback to 
CARE? 
“You have that exit survey, which is good since things are fresh in your mind, so 
if I had something to say I can use that form. I think a survey is more important 
than having a [comment] box, so everyone does it.” —57 year old Caucasian 
Male, Stage 4 Colon Cancer Survivor  
 
“Its okay. They have the survey, but they are rushing.”—59 year old 
Asian/Pacific Islander Female, Stage 4 Stomach, Breast, and Ovary Cancer 
Survivor 
 
“I like the one on one approach. I know I can talk to anybody there. I would like 
to come up to you...I know I have [the CARE manager’s] office number and I 
can call her. I haven’t called, but I have her number”—69 year old Caucasian 
Female Stage 2 Breast Cancer Survivor 
Design of survey “Do one of the survey things online with like 10 questions and say it take 5 
minutes, so you know. Otherwise you can take a survey and its like oh my god, 
its so many questions.” —57 year old Caucasian Male, Stage 4 Colon Cancer 
Survivor  
 
There were several questions asked to determine what is most valued and gained from 
participating in CARE, including questions about why people joined CARE, what they feel is the best 
part of CARE, and what makes them return to CARE. All eight interviewees mentioned how important 
it was for them to gain social support from other cancer survivors in the CARE program. Some 
mentioned education as being important as well. Table 4 and Table 5 shows quotes presented 
thematically to illustrate what value CARE brings to its participants. Those interviewed talked about 
how important speaking to cancer survivors is to gaining things such as experiential knowledge of what 
is to come, hope, inspiration, acceptance of diagnosis, and emotional support. Participants felt these 
were things doctors couldn’t necessarily give, but peer cancer survivors from CARE could. Social 
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support from CARE seemed to drive people to have positive changes that could affect their health such 
as feeling less anxious, sleeping better, managing life better, and improving emotional wellbeing.   
 
Table 4 
 
In-Depth Interview Quotes Regarding the Value Gained From CARE  
Main questions/ 
comment type 
Quotes 
Why did you 
decide to join 
CARE? 
“My daughter she doesn’t get it. People don’t get it. My friends are like what do 
you mean you have cancer, you don’t have cancer, you’re a cancer survivor. But 
somewhere in my mind its still there. Did it all go away? No! I still have to take 
medicine. I still need to go to therapy. And my life in still in the drain. So, it’s 
still like I am going through it. I am still dealing with the pain relating to this, 
[cancer]… I thought it would be good to be around other [cancer survivors].”—
69 year old Caucasian Female, Stage 2 Breast Cancer survivor 
 
“When you are really sick you need someone to talk to because in your family, 
sometimes it is hard to discuss what your feeling is, but with others with the 
cancer its like they know what your are feeling.”—59 year old Asian/Pacifica 
Islander Female, Stage 4 Stomach, Ovary, and Breast Cancer Survivor.  
 
“My father was a psychologist, so I know how important these things are on a 
emotional level, on a educational level I know these support groups can be 
really important. Plus there are details only people going through these things 
can understand.  And so that feels good. It feels nurturing to find people.” —57 
year old Caucasian Male, Stage 4 Colon Cancer Survivor  
 
What about 
CARE keeps you 
coming back? 
“I thought it would be good to be around other [cancer survivors] and it was. I 
am very private person, so it was special.”—69 year old Caucasian Female, 
Stage 2 Breast Cancer Survivor 
 
“The people keep me coming back because people care. You get to know people 
and they are my friends now. You know we have this time every week. If you 
missed it and you are like damn I missed CARE. Its the camaraderie and 
everyone is having a good time.”—51 year old African American Female, 
Multiple Myeloma 
 
The recurring theme of the in-depth interviews indicated that social support is vital to CARE and 
should be examined further. Participants stated they are coming to CARE for social support and 
information they cannot get from their physician, and that participants are returning to CARE because 
CARE has a caring, understanding environment with a sense of camaraderie and it can be fun. 
Participants believed they are getting the support that is good for the body and the soul, they are feeling 
DEVELOPING	A	PEER	CANCER	SUPPORT	GROUP	EVALUATION	
	
22	
22	
less anxious, sleeping better, managing their life better, and getting hope and emotional support. Social 
support may not only be key to understanding how efficacious CARE is, but it may indicate that other 
health promoting benefits being gained from participating. From the testimony it seems like social 
support may indicate small improvements in social wellbeing, emotional welling, physical wellbeing 
and more. 
Pre-survey Interview Findings 
Table 5 
 
In-Depth Interview Quotes Regarding the Value Gained From CARE  
Main questions/ 
comment type 
Quotes 
What have you 
gained from 
coming to 
CARE?  
“There are details only people going through these things can understand.  And 
so that feels good. It feels nurturing to find people [other cancer survivors]…I 
think that type of support we have in CARE and that type of networking its good 
for the soul. What’s good for the soul is good for the body. Healthy mind, 
healthy body”.—57 year old Caucasian Male, Stage 4 Colon Cancer Survivor.  
 
“[CARE], it made me feel less anxious and that I am not alone. It’s a big thing 
because like I said my daughter and my friends don’t quite get it. I am feeling 
like someone gets].”—69 year old Caucasian Female, Stage 2 breast cancer 
survivor 
 
“I [benefitted from CARE] by accepting [my cancer]. I hear other people 
speaking about it and they are more sicker and they survive. They are my 
heroes. I cannot sleep because I no accepting, but now I accepting—I sleep a 
little bit more. Also the medicine helping me. When you are accepting why are 
you sick, you are accepting why you are tired, you accepting why [you have 
symptoms], you accepting that people look at you different.”— 53 year old 
Latina Female, Stage 4 lung cancer survivor 
 
“CARE got me to a point where I can manage my life again and give back and 
try to help people. There are a couple members in the group that I talk to when 
they first came in and there were people who talked to me when I first came 
in…There is a sense of commonality, comfort, and support that people have 
toward one another that they get for themselves.”—69 year old African 
American and Caribbean, Chronic Lymphocyte Leukemia   
 
“When you meet many people who are surviving. It gives you hope. It is 
probably the biggest thing I gotten from CARE is the hope [from other cancer 
survivors]. It has definitely affected me emotionally.”— 51 year old African 
American Female, Multiple Myeloma 
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 There were 25 pre-surveys done with a few not being fully completed. Table 6 shows the 
demographic statistics for age, gender, race/ethnicity, and financial stability. The average age was about 
62 with the youngest being 50 years old and the oldest being 79 years old. There were more females 
than males. The largest racial/ethnic group was Asian/Pacific Islanders followed by Caucasians and 
African/African Americans. Most who were surveyed are somewhat financially instable.  
Table 6 
 
Pre-survey Demographic Information 
Age  
Average (Range) 62(50-79) years old 
 Gender 
Percent (Number) Male: 40%(10)  Female 60%(15) 
Race/Ethnicity 
Percent (Number) 
African/African 
American 17%(4) 
 
Asian/Pacific Islander 42%(10) 
 
Caucasian 29%(7) 
 
Latino/Chicano 8%(2) 
 
Other 4%(1) 
Financial 
instability  Instable  12%(3) 
 
Somewhat instable 64%(16) 
 
Stable 24%(6) 
Cancer types, stages, and places in cancer continuum and shown in Table 7 located in appendix 
E. Participants indicated they have single and multiples cancers. Stages 1 to 4 were represented and 
some did not indicate their stage or did not have a diagnosis with a stage. Stage 4 had the highest 
representation and Stage 1 had the lowest. There were ten different cancers represented with the most 
common being breast cancer, followed by chronic lymphocyte leukemia and lung cancer. People were in 
various places in the cancer care continuum, but the most common place in done with treatment for over 
a year with the second most common place being currently in treatment within the last 6 months.  
 Data on how familiar people were with CARE and how long they have attended was collected. 
Table 8 in appendix F shows how familiar participants are with CARE and how long they have been 
members of CARE. Most were CARE veterans meaning they were very familiar with CARE. The 
CARE veterans had an average of 7 years participation in CARE and ranged from 2 to 11 years in 
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CARE. A few said they were new to CARE and on average spent only 1 month in CARE. The average 
length of membership was 3.5 years with the longest being 11 years, and the shortest being brand new to 
CARE. This information may be valuable to examine the dosage effect.  
Data on perceived social support from an adapted perceived social support survey tool included 
in the pre-survey was collected and converted into quantifiable data. The social support survey tool had 
five items scored by Likert scale using a converted numerical score -2 to 2, with -2 being the lowest 
score and 2 being the high score for each item. In total the lowest possible score was -10 indicating the 
lowest perceived social support and the highest possible score was 10 indicating the highest perceived 
social support. From the surveys, the average perceived social support score was about 5, with the 
highest being 10 and the lowest being -5.  
Table 9 
 
Reasons participants joined CARE 
Main reason for joining 
CARE 
Percent (Number) 
To talk with other cancer survivors who 
understand 70%(19) 
 
To get emotional support 63%(17) 
 
To learn about cancer from presenters 63%(17) 
 
To get connected to resources 30%(8) 
 
To get a healthy dinner 33%(9) 
 
Other  11%(3) 
There were a variety of reasons people joined CARE. Most people selected more than 1 reason. 
Table 9 shows the reasons, and the percent and number of participants who selected each reason.  The 
most common reason people came was to talk to other cancer survivors who understand followed by to 
get emotional support and learn about cancer from presenters. A minority of participants joined CARE 
to get connected with resources and to get a healthy dinner. A few selected other and wrote something 
about sharing and inspiring others battling cancer. The data showed that not only was social support 
important to the interviewees, but also to the majority of people who were surveyed. This aligns with 
what was seen in the in-depth interview.  
DEVELOPING	A	PEER	CANCER	SUPPORT	GROUP	EVALUATION	
	
25	
25	
Implications for practice 
The project goal was to evaluate CARE, a peer cancer support group. The project was necessary 
since CARE staff needed to understand the efficacy of the program in order to substantiate stakeholder 
support and to improve the CARE program. In order to evaluate it, in-depth interviews were conducted 
to discern value CARE provides to its participants. From the interviews social support seemed to 
provide the most value as it was most commonly mentioned as the reason people came to CARE and 
returned to CARE, and it was what participants gained from CARE. This led to us using a perceived 
peer survey tool in our quantitative survey. By evaluating perceived social support, it can help CARE 
staff understand how much social support CARE participants gained. The survey may also assist CARE 
staff in improving the program by helping them decide to further focus on social support.   
The in-depth interviews were key to conducting this evaluation because it brought CARE 
participants’ voices into the discussion around how to determine CARE’s performance. Understanding 
the efficacy of CARE from the lenses of participants aligns both program and participants goals. It also 
led to the design of the survey. I recommend collecting qualitative data like the quotes collected from 
the in-depth interviews because it gives detail explanations on what participants want from the peer 
support group, and why they want it and why it is important.  
The quantitative surveys were key in accomplishing the project goal because it corroborates what 
was heard in the in-depth interviews, and it provides information CARE staff need. Both the in-depth 
interviews and surveys indicated that social support is desired. Social support was the main reason why 
people participate in CARE. Since particular stakeholders want quantitative data, the quantitative survey 
results meet CARE staff needs. The quantitative data can address a major threat to CARE of not having 
quantitative data to defend the support of the program, and possibly not being able to obtain the support 
of stakeholders and expanding funding sources. The quantitative data can be used to justify and improve 
new and existing stakeholder support.  
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There are several reasons why qualitative and quantitative data were used to evaluate this 
program. The reasons include complexity of cancer survivorship, diversity of support needed, and board 
goal of the CARE program. This set of challenges made it hard for a researcher and a community 
program designer to determine the type of evaluation needed to assess program performance and 
participant needs. If other peer support programs have a similar challenges as CARE, I recommend 
collecting qualitative and quantitative data similar to what is shown in this paper. In-depth interviews 
informing the quantitative survey development seemed to work well for the project goal and the CARE 
staff needs.    
Discussion  
 Developing the evaluation of CARE was not a simple task. The program and lack of literature 
provided challenges. The program provided challenges since the original vision, mission, and objectives 
were broad and needed some revision. They could not be used to specify what constructs need to be 
evaluated. The lack of literature provided challenges since limited standard methods and survey tools to 
evaluate cancer support groups were identified. No best practices on evaluating peer cancer support 
groups such as methods and tools were known. To address this challenge, in-depth interviews were 
conducted to help inform the survey development. Questions from the in-depth interview were designed 
to determine what CARE participants’ value the most from attending CARE. Social support was a 
recurring theme in all the in-depth interviews, so the perceived social support construct was used to 
make quantitative surveys that could evaluate CARE’s performance and give clues to what needs 
improving. Social support seems like a promising construct because the surveys showed that 
participants’ main reason for joining CARE indeed was to talk with others. The social support construct 
is also promising because CARE participants testimonies show the variety of benefits gained from social 
support that range from social benefits, emotional benefits, physical benefits, and to even more. There 
even can be a possibility these benefits are health and wellbeing related.  
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Challenges in Evaluating Peer Cancer Support Groups in the Literature 
 The challenges I faced and my findings were also seen in the literature. In the Campbell, 
Phaneuf, & Deane, 2004 systematic review, the authors discussed the challenges researchers had in 
evaluating peer support groups. Campbell, Phaneuf, & Deane’s 2004 review discussed how studies 
lacked a thorough and clear description of the program, and had methodical flaws amongst other 
challenges. A different systematic review on cancer support groups also discussed the methodical 
challenges, but went on to suggest that methodical problems could be due to the inappropriate outcome 
measures used (Hoey, Ieropoli, White, Jefford, 2008). Another systematic review summarized 
evaluation issues in three parts that link the methodical flaws with program plan flaws (Gottlieb & 
Wachala, 2007). The first is that the cancer support group planner needs to be clear as to whether the 
group is supposed to cause the outcome of interest or be the stepping-stone toward the outcome 
(Gottlieb & Wachala, 2007). The second is that the program planners rarely consult participants in 
determining the desired outcome, which could result in nonmatching desired outcome (Gottlieb & 
Wachala, 2007). The third is attrition and performance may be low if program planners don’t match 
their outcome goals and measures with goals desired and expected by the participants (Gottlieb & 
Wachala, 2007).  The challenges reported in the literature regarding program design and evaluation 
design is similar to challenges seen in CARE prior to this project. 
Addressing Challenges 
 I addressed the evaluation design challenges stated above by seeking the CARE participants’ 
input. By interviewing them, I allowed them to tell me in their own words what mattered to them and 
what value CARE brought to their lives. Social support was what they were after, needed, and what they 
gained from CARE. The perceived social support construct was actually different from what I and 
CARE staff were initially thinking of measuring. Initially, we were thinking of measuring health-related 
quality of life, but there were issues with using that measure since a lot more than the cancer support 
group affects quality of life. The reason why we were attracted to health-related quality of life construct 
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was because we were formally trained in health and were in a hospital setting, so we felt hospital 
stakeholder would be most satisfied with this construct Health-related quality of life was initially 
thought of since the ultimate goal of the hospital is to improve the health of the community. However, if 
quality of life were selected the change between the pre-survey and post survey may report no or 
negative change, not accurately reflecting the efficacy of the program. There might be no or negative 
change in health-related quality of life if other factors such as disease progress or financial burden 
happens to negatively affect CARE’s participants during the study. Given our population is vulnerable, 
there is a high chance this can happen. A poor selection of construct to measure can lead to poor 
reporting of efficacy and lost support for CARE, a possible result not necessarily warranted.  
Instead of choosing health-related quality of life, we decided to allow participants to choose the 
construct by telling us what they valued and gained from CARE. This approach solves some of the 
challenges regarding disconnect between participants goals and program planner goals. The social 
support construct is a much more appropriate measure because it aligns the desired outcomes of the 
CARE peer cancer support group as well as the participants. From qualitative evidence, it seems like 
social support is more obtainable with CARE, and it accurately describes what participants get from 
CARE. Our methods solves challenges stated in Gottlieb & Wachala’s 2007 review because we know 
social support can be a step toward health-related benefits as described above, social support is 
something both us and participants are interested in, and this alignment of interest can improve 
programing in the eyes of both the program planner and participants.       
Limitations 
 There are several limitations in conducting a full rigorous evaluation of CARE. A major 
limitation had to do with the timing. The projected needed to be done within the period of an internship, 
but that did not match up with the CARE seminar series; therefore, only the in-depth interviews and pre-
survey was done. The post survey will be conducted at the end of the CARE summer seminar series in 
late August 2017. Another timing issue had to do with when the pre-survey was conducted. The pre-
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survey was not conducted the first day of the summer seminar series due to prior commitments CARE 
staff made to presenters. However, if the pre-survey was done on the first day there may not be enough 
time to have all the schedule presenters and field the survey. On the second day there was ample time to 
finish the survey. A limitation of conducting the pre-survey on the second day is that, it might not reflect 
what social support was before coming to CARE. Peers may have connected on the first day and the 
perceived social support might have increased, so the change in perceived social support might show as 
lower between the pre-survey and post-survey.  
 There were sample limitations. Since there were only eight in-depth interviews and 25 pre-
survey participants, the data might not have reflected what would be seen if all of CARE participants 
were interviewed and surveyed. With this small sample size, nothing definitive and statistically 
significant can be said about the CARE program. The sample was also a convenience sample of those 
willing and able to complete the in-depth interviews and pre-survey. I did not sample all the CARE 
participants, only people who were present and willing to be sampled. I also did not compare perceived 
social support of the CARE participants with ZSFG cancer survivors who do not attend CARE. 
Comparing perceived social support between those two groups can help demonstrate how perceived 
social support differs between CARE participants and non-CARE participants. Also since ZSFG cancer 
patients are unique and tend to be low-income and vulnerable, generalizing the findings to other cancer 
support groups is not advisable.  
There are limitations in regards to the design of the survey. Written survey might also not be the 
best for those who lack literacy. Since the surveys were completed during the CARE session, people 
might not be fully truthful. Steps were taken to try to reduce pressure felt on displeasing staff by having 
interns and volunteers pass out and collect surveys. Survey were given during the session, so people are 
motivated to do it at that moment instead of taken home and forgotten. Asking for names on the survey 
may be a big limitation. People might not want to be fully truthful since they identified themselves and 
do not want to be too displeasing. Ways I tried to address this anxiety from writing their names on the 
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survey was saying the data will be pool together in a report, and will not affect their participation in 
CARE. 
 Another limitation of the project is that social support might not be what potential stakeholders 
from ZSFG want to know. Since CARE is housed in a hospital where health is of primary interest, 
perceived social support may not be what stakeholder want to know. Instead they might want something 
akin to health-related quality of life, but this construct is complicated to use for a program evaluation in 
ways discussed previously. One way we address this issue is by reporting ways social support has 
affected health-related factors such as sleep, emotional stability, and more as described by CARE 
participant testimony. In addition, there are many studies showing the linkage of social support with 
health-related benefits (Eisenberger, 2013). 
CARE Recommendations 
 I recommend that CARE continue to investigate the social support aspect of CARE. It was 
shown to be a highly valued feature of CARE. A major reason people come to CARE is to speak with 
other cancer survivors. Both the in-depth interviews and the surveys showed that. Social support may 
also be promising because it can be a steppingstone to other desired health-related benefits such as 
improved sleep and emotional wellbeing. There may be other health-related benefits not captured in the 
interviews that use social support as a vehicle to improve health, so that should be explored. The 
mechanism seems to be that participants are getting social support from cancer survivors at CARE then 
getting experiential knowledge from others, gaining camaraderie, and building hope— leading to a more 
peaceful and productive life. This mechanism can be further explored and described to gain stakeholder 
support. 
 Having a short paper survey available during sessions seems the most sensible for obtaining data 
from CARE participants. Participants seemed to be okay with the paper surveys and even said it was 
best to complete the survey during CARE, so feedback is fresh in their minds. Giving immediate 
feedback may be important as ZSFG cancer survivors have many adversities and may not have the time 
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to complete the survey later. Short, clear and concise surveys are preferred since long surveys may be 
disliked by participants and may not get completed. Paper survey also were preferred since some CARE 
participants are older and may not be used to taking electronic surveys; however, in the future CARE 
participants may be open to online or electronic surveys.   
CARE staff should use the surveys provided or design a survey similar to the one provided in the 
future. From the pilot pre-survey feedback, the post-survey can be improved by using a simpler worded 
Likert scale for the perceived social support survey. The wording is already modified in the surveys 
provided in appendix C and D. The previous wording in the pilot pre-survey made at least two CARE 
participants confused, so rephrasing was needed. Following the design of the post survey in appendix C 
and D for future surveying can help. 
 To satisfy certain stakeholders who needed health-related quantitative results, taking an 
inventory of health-related benefits since attending CARE may help. In the post-survey there is an 
inventory of health-related benefits; however, this inventory can expand. I suggest noting other health-
related benefits and adding it to this inventory, so that information is captured. Showing the number and 
percentage of those gaining various health-related benefits may be what certain stakeholders want.   
Suggestions for Research 
Currently literature does not provide a standard method to evaluate peer cancer support groups, 
so I suggest further research to make this possible. Research would need to bring many different key 
stakeholders together such as program planners, funders, cancer care experts, cancer survivorship 
research experts, and most importantly cancer survivor social support participants. Ideally, what is 
evaluated should be a common construct of interest held by all the stakeholders listed.  
A gold standard quantitative survey tool that measures efficacy of peer caner support groups can 
make evaluation easier. More research should be done to work toward a gold standard survey tool. 
Having such a tool can make it easier to conduct a survey and compare programs. A standard survey 
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tool could make evaluation easier, but it will be difficult to develop since there are various program 
designs, populations of cancer survivors, and other complicating variables.  
Another important suggestion for cancer support research is to understand the mechanisms of 
how peer support amongst cancer survivors leads to health benefits. A goal of some peer cancer support 
programs is to improve health. Therefore, understanding mechanism for adopting healthier practices 
through peer influence may be key in knowing what it takes to improving health and programing. To 
understand these mechanisms it is appropriate and necessary to employ qualitative research methods that 
gives more descriptive information. 
Once extensive research is done on social support group evaluation, I urge an authority in cancer 
care to provide best practices on evaluation. This should include evaluation methods, quantitative survey 
tools, and justification on why these best practices work. If it is outlined, more peer cancer support 
groups can conduct rigorous and accurate evaluations. This type of evaluation can help peer cancer 
support group gain sponsor support, and improve programing.  
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Appendix	A		
SWOT Analysis Table 
SWOT Analysis Table 
 
Table analysis strengths, weaknesses, opportunities, and threats 
Strengths Weaknesses 
• CARE has loyal participants who have been 
coming for years 
• CARE was created when there was little 
cancer survivorship research on best 
practices  
• CARE is one program within the Community 
Wellness Program that has many health and 
wellness promoting programs  
• CARE’s mission and goals are very broad  
• CARE is in ZSFG which is where participants 
get medical care 
• CARE staff has not done an extensive 
formal evaluation capturing what 
participants consider most valuable about 
CARE  
• CARE has established a network of loyal 
guest speakers 
• CARE has not created evaluation 
protocols based on a standard  
• CARE gets referrals from clinics and partners 
with clinical departments 
• CARE is not getting many referrals from 
other clinics such as Urology, Geriatric 
Clinic, Neurology, Pain consultation, 
Plastic Surgery, Pulmonary, and 
Dermatology 
• CARE already has relationships with 
foundations that could fund 
• CARE’s pool of endowment money have 
been diminishing 
Opportunities Threats 
• CARE staff can ask participants and guest 
speakers for feedback 
• There is no national standard method and 
survey tool to evaluation cancer peer 
support groups  
• CARE staff could get advice and feed back 
from non-CARE Community Wellness staff 
that run community based programs 
• If CARE does not get funding it need to 
operate, CARE could die 
• ZSFG clinical staff and CARE staff can work 
together to serve CARE participants 
• CARE participants have limited resources 
and knowledge to help CARE initiatives 
continue by themselves 
• CARE would work with community 
organizations outside of ZSFG to gain support  
• Clinics referring to CARE are not getting 
updates from CARE and they may not see 
how CARE participants’ health or 
wellbeing are improving  
• The foundations that have a relationship with 
CARE can give CARE feedback on the 
program and advise on how to gain more 
support, especially financial support 
• It may be hard to substantiate sustaining 
CARE if other cancer support programs 
offer the exact same value.  				
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Appendix	B	
Interview	Data	Collection	Form		
Interview	number:	_____	 	 	 Date	conducted:	__-__-____	(MM-DD-YYYY)	
Interviewer:	________________________________		
Interviewee	information:		
Type	of	cancer(s):________________		 Date	diagnosed:	__________	
Interviewee	gender:	________	 	 	Interviewee	age:	_______	
Interviewee	racial/	ethnic	group	(Circle	One):	Asian/Pacific	Islander	American				African	American					Caucasian	American																	Latino	American				Other	(describe):		
	
Number	of	times	attending	CARE:	___________	
Date	of	last	CARE	session	attended:	__-__-____	(MM-DD-YYYY),		
CARE	session	topic:	___________	
	
Notes:	Reasons	Participants	Attend	CARE,	Return	to	CARE,	and	Enjoyed	About	CARE:	I. INDIVIDUAL	CIRCUMSTANCES	AND	NEEDS	a. Circumstances	and	Needs	
i. Tell	me	about	your	experience	being	diagnosed	with	cancer.	1. What	were	you	most	concerned	about	when	you	were	diagnosed?	2. What	did	you	need	help	with	once	you	were	diagnosed?	____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________	
Probe:	
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II. CARE	EXPERIENCE			a. Getting	involved		
i. How	did	you	end	up	getting	involved	CARE?	1. How	did	you	hear	about	CARE?	
ii. Why	did	you	decide	to	come	to	CARE	when	you	did?	
iii. About	how	many	CARE	sessions	have	you	been	to?	OR	How	long	have	you	
participate	in	CARE?	
iv. How	long	do	you	plan	to	participate	in	CARE?		1. [If	they	plan	to	return]	What	keeps	you	coming	back	to	CARE?		2. [If	they	plan	to	return]	What	are	things	that	prevent	you	from	coming	to	CARE?		_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________	b. Expectation	and	feedback	on	CARE	sessions	
i. Before	you	got	involved	with	CARE,	what	did	you	hope	to	learn	or	get	from	CARE?	1. When	you	joined	CARE	was	there	anything	you	experienced	in	the	CARE	group	that	surprised	you?	If	so,	what	was	it?		ii. In	general,	how	would	you	describe	your	experience?		1. What	is	the	best	part	of	CARE?	2. What	part	of	CARE	would	you	change?	___________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________	c. Value	obtained	by	CARE		
i. How	have	you	benefitted	from	participating	in	CARE?		
ii. What	do	you	gain	from	being	a	part	of	CARE?		1. How	did	your	experience	with	CARE	affect	your	life?		___________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
Probe:	
Probe:	
Prob
Probe:	
Probe:	
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___________________________________________________________________________________________________________________________________________________________________________		Suggestions	for	CARE:	III. OPINION	ON	THE	VISION	OF	CARE	a. Developing	the	Vision	of	CARE	with	the	participants	
i. We	are	working	on	a	motto	that	summarizes	what	CARE	stands	for.	In	
one	phrase	describe	what	CARE	should	stand	for?	1. What	should	CARE’s	motto	be?	________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________		IV.	 GETTING	FEEDBACK		b. Asking	for	feedback	in	the	future	
i. If	you	had	a	suggestion	or	a	comment	about	a	CARE	session,	how	would	
you	communicate	it?	1. Would	you	feel	comfortable	giving	feedback	in	person	to	staff?	If	so,	who?	2. Would	you	feel	comfortable	giving	feedback	on	the	phone?		3. Would	you	feel	comfortable	giving	feedback	in	a	survey,	online	or	paper,	after	the	CARE	session?		4. Would	you	feel	comfortable	giving	feedback	through	an	anonymous	comment	box?	c. Feedback	on	CARE	
i. Is	there	anything	else	you	want	to	share	with	me	about	CARE?	_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________		
Probe:	
Probe:	
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Other	competing	support	programs:	V.	 OTHER	RESOURCES		a. Other	resources	used	by	CARE	participants	
i. What	other	support	programs	are	you	involved	in?	1. What	do	you	get	from	that	support	program	that	you	don’t	get	from	CARE?	
ii. If	CARE	didn’t	exist	where	else	or	how	else	would	you	get	the	support	you	
get	from	CARE?	_________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________	
Closing	statement:	Thank	you	so	much	for	participating	in	this	interview.	The	information	you	provided	is	valuable	and	will	help	CARE	evolve,	so	CARE	can	provide	the	best	support	to	its	participants.		In	the	future,	if	you	have	questions,	comments,	or	need	support,	please	contact	me	at	Glenda.Kith@sfdph.org	or	come	to	the	Community	Wellness	Center.																 	
Probe:	
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Appendix	C	
CARE Pilot Pre-survey (English)  
This survey is confidential. It will be combined into a report, and provided to CARE 
for program improvement. Your responses will NOT affect your participation in 
CARE.  
1. Name: First, Last initial _____________________, ____. 
2. What is your age? _________   
 
3. Gender:  Male    Female    Other
4. Race/Ethnicity: (Check ALL that apply)  
 African American/African   
 Caucasian                                
 Asian/Pacific Islander    
 Latino/Chicano 
 
5. Are you: (Check ONE) 
 (1)New to CARE   
 (2)Somewhat familiar with CARE    
 (3)CARE Veteran 
5a. How long have you attended CARE (months/years)? ______/_______ 
6. Describe your circumstances when you first joined CARE: (Check ONE) 
 I have been diagnosed with cancer 
  I have not been diagnosed with cancer, but I am a family 
member/friend of someone diagnosed with cancer. If you selected this 
option SKIP question 7.  
 
Continue to the next page. 
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7. Where are you in the cancer process? (Check ALL that apply) 
                  
 
 
 
8. Who told you about CARE? (Check ALL that apply) 
  Friend  
 Medical Provider   
 Cancer Navigator     
 Social Worker  
 Community Wellness Center Staff  
 Other: __________________  
 
9. Do you feel you heard about CARE… 
 Too early    
 At the right time     
 Too late 
   Why?:____________________________________ 
 
10. In the past 12 months I was in extreme financial need and didn’t have 
money to pay rent, housing bills, food and/or medicine… 
 Often True    
 Sometimes True    
 Never True 
 
 
 
Continue to the next page. 
Diagnosed	with	cancer	in	the	last	6	months	
 		
Currently	in	cancer	treatment	Within	last	6	months	
 	
Done	with	treatment	in	the	previous	year	
 		
Done	with	treatment	over	a	year	ago	
 		
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11. What is the main reason you first came to CARE? (Check ALL that apply) 
  To talk with other cancer survivors who understand  
  To get emotional support  
 To learn more about cancer from presenters 
 To get connected to resources such as meal assistance, housing, etc. 
  To get a healthy dinner 
 Other: __________________________________________________ 
 
Below is question regarding social support (Check one box in each line) 
12. Please read each statement 
and indicate how much you 
agree of disagree. 
Definitely 
Yes  
Yes Neither 
yes or no 
No Definitely 
No 
12a. I know someone I can 
confide in about my problems 
relating to cancer. 
     
12b. I have someone who can 
give me advice on crises 
relating to my cancer. 
     
12c. I have someone who gives 
me information to help me 
better understand my cancer. 
     
12d. I have someone to help 
with daily chores if I was sick. 
     
12e. I have someone I can have 
a good time with. 
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12.  Tell us how you hope CARE could help you improve your life. 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
 
 
13. What cancer do you have? (OPTIONAL, Answer only if comfortable) 
Stage:   Stage 1  Stage 2  Stage 3  Stage 4  																							 	
Last Page.  
 
Thank you for participating!  
This information will help us improve CARE. 	
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Appendix D 
CARE Post-survey (English) 
This survey is confidential. It will be combined into a report, and provided to CARE 
for program improvement. Your responses will NOT affect your participation in 
CARE.  
1. Name: First, Last initial _____________________, ____. 
2. What is your age? _________   
 
3. Gender:  Male    Female    Other
4. Race/Ethnicity: (Check ALL that apply)  
 African American/African  
 Asian/Pacific Islander     
 Caucasian                                
 Latino/Chicano 
 
5. Are you: (Check ONE) 
 (1)New to CARE  
 (2)Somewhat familiar with CARE    
 (3)CARE Veteran 
5a. How long have you attended CARE (months/years)? ______/_______ 
6. What is the main reason you first came to CARE? (Check ALL that apply) 
  To talk with other cancer survivors who understand  
  To get emotional support  
 To learn more about cancer from presenters 
 To get connected to resources such as meal assistance, housing, etc. 
  To get a healthy dinner 
 Other: __________________________________________________ 
Continue to the next page.	
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7. Attending CARE has prepared me to…  Agree  Disagree Neither 
agree or 
disagree  
7a. Better accept my cancer diagnosis     
7b. Select a cancer treatment plan     
7c. Better manage my side effects (such as pain, focus, 
etc.) 
   
7d. Emotionally deal with my cancer    
7e. Eat healthier    
7f. Sleep better    
7g. Exercise more regularly     
7h. Communicate better with my health provider     
7i. To connect with other cancer support programs 
(such as Project Open Hand, Second Opinion, etc.)  
    
7j. Communicate better with my loved ones about my 
cancer  
    
7k. Become more productive at work or home    
7l. Be more aware of my physical, mental and 
emotional issues 
   
 
7m. Other: Specify:_________________________ 
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Continue to the next page 
Below is question regarding social support (Check one box in each line) 
8. Please read each statement and 
indicate how much you agree of 
disagree. 
Definitely 
Yes 
Yes Neither 
yes or no 
No Definitely 
No 
8a. I know someone I can 
confide in about my problems 
relating to cancer. 
     
8b. I have someone who can 
give me advice on crises relating 
to my cancer. 
     
8c. I have someone who gives 
me information to help me 
better understand my cancer. 
     
8d. I have someone to help with 
daily chores if I was sick. 
     
8f. I have someone I can have a 
good time with. 
     
 
9.  What would you like CARE to change? (Check all that apply) 
 More time to check-in in a group if people have updates and news to tell 
 Having more time to socialize at the end 
 Having CARE staff drop-in office hours   
 Healthier food choices    
 Other (if no changes desired write “None”):___________________________  
10.  What cancer do you have? (OPTIONAL, Answer only if comfortable) 
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Stage:   Stage 1  Stage 2  Stage 3  Stage 4 
 
11. Do you have comments or feedback on CARE?  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Last Page. 
 
 
Thank you for participating! This will help us improve CARE. 
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Appendix E 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 																				 	
Table 7 
 
Pre-survey Cancer Information 
Cancer type Breast 6 
 
Chronic Lymphocyte Leukemia 2 
 
Colon 1 
 
Gallbladder 1 
 
Lung 2 
 
Lymph 1 
 
Myeloma 1 
 
Stomach 1 
 
Thyroid 1 
 
Tongue 1 
 
Prefer not to say 8 
Stage Stage 1 1 
 
Stage 2 5 
 
Stage 3 2 
 
Stage 4 7 
 
No stage indicated 10 
Place in Cancer 
Continuum Diagnosed with cancer 6 months ago 3 
 
Currently in treatment within the last 6 months 8 
 
Done with treatment in the previous year 3 
 
Done with treatment over a year ago 9 
 
Nothing indicated 3 
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Appendix	F	
	
		 Table 8 
 
Familiarity with CARE 
Familiarity 
with CARE 
Percent 
(Number) New to CARE 21%(5) 
 
Somewhat Familiar with 
CARE 29%(7) 
 
CARE Veteran 50%(12) 
Length of 
CARE 
membership  
Average 
number of 
years (Range) 3.5 years (0-11 years) 
 
